Top Philippine Fintech Mynt Doubles QoQ Earnings
Cements Role in Driving an Inclusive Digital Economy in the Southeast Asian Nation MANILA, Philippines, May 18, 2026 /PRNewswire/ -- Mynt, Inc., the parent company of the Philippines' number one finance superapp, GCash, continued to deliver...
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
HAIKOU, China, May 14, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual market...
Health In Tech Reports First Quarter 2026 Financial Results
Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla., May 14, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today...
Yum China Announces US$512 Million Share Repurchase Agreements for Second Half of 2026 as Part of US$1.5 Billion Full-Year Capital Return Plan
SHANGHAI, May 12, 2026 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that it has entered into share repurchase agreements in the U.S. and Hong Kong for an aggregate repurchase amount of...
PowerX Signs MOU with Montenegro's National Utility EPCG for Strategic Cooperation on Battery Energy Storage
TOKYO, May 11, 2026 /PRNewswire/ -- PowerX, Inc.(Head Office: Tamano City, Okayama Prefecture; Director, President and CEO: Masahiro Ito; Securities Code: 485A) signed a Memorandum of Understanding (MOU) on May 7th with Elektroprivreda Crne Gore AD...
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as...
Autoliv Announces Results of 2026 Annual Stockholders Meeting
STOCKHOLM, May 8, 2026 /PRNewswire/ -- Autoliv, Inc., (NYSE: ALV and SSE: ALIV.sdb), the worldwide leader in automotive safety systems, today announced the results of its annual general meeting of stockholders held on May 7, 2026. Annual General...
NetEase to Report First Quarter 2026 Financial Results on May 21
HONG KONG, May 7, 2026 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the 2026 first quarter on...
Youdao to Report First Quarter 2026 Financial Results on May 21
HANGZHOU, China, May 7, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an AI solutions provider specializing in learning and advertising, today announced that it will report its first quarter 2026 financial results on...
Blaize Announces Pricing of $35 Million Public Offering of Common Stock
EL DORADO HILLS, Calif., May 6, 2026 /PRNewswire/ -- Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) ("Blaize," the "Company," "we," "our," or "us"), a leader in programmable, energy-efficient AI computing, announced today the pricing of its...